◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Carna Biosciences,Inc. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 636.2M 1.6B 1.4B 2.0B 1.1B
Revenue Growth % -60.9% 17.2% -31.3% 78.0% --
+Operating Income -2.1B -1.1B -1.3B -531.1M -1.1B
Operating Margin % -326.3% -68.7% -91.6% -26.3% -93.3%
Non Operating Income 44.1M 756,000 5.6M 24.3M 2.7M
Non Operating Expenses 48.7M 10.1M 14.5M 16.2M 22.8M
Ordinary Income -2.1B -1.1B -1.3B -523.0M -1.1B
Income Before Taxes -2.2B -1.1B -1.3B -532.5M -1.1B
Income Taxes 4.6M 22.0M 26.1M 2.0M 8.5M
+Net Income -2.2B -1.2B -1.3B -534.5M -1.1B
Net Margin % -342.4% -70.9% -97.3% -26.5% -98.0%
Eps -121.64 -68.62 -99.10 -42.10 -90.33
Depreciation Amortization 31.2M 35.6M 33.8M 19.2M 12.4M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Deposits 2.1B 2.9B 3.4B 3.8B 4.3B
Current Assets 2.7B 4.2B 4.1B 5.3B 4.7B
Property Plant Equipment -- 105.5M 100.2M 51.6M 53.3M
Noncurrent Assets 34.4M 158.4M 162.1M 114.1M 127.2M
Total Assets 2.8B 4.3B 4.3B 5.4B 4.8B
Current Liabilities 223.0M 375.9M 436.4M 774.7M 727.2M
Total Liabilities 296.8M 472.4M 624.6M 1.1B 1.0B
Retained Earnings -6.3B -4.1B -2.9B -1.6B -1.0B
Total Equity 2.5B 3.9B 3.6B 4.3B 3.8B
Equity Ratio 0.89 0.89 0.85 0.79 0.79
Book Value Per Share 129.62 226.16 255.04 323.54 308.05
Num Employees 63.00 67.00 65.00 64.00 64.00
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Operating Cash Flow -1.4B -1.7B -708.4M -1.5B -1.3B
Investing Cash Flow -13.1M -11.4M -125.7M -41.7M -70.4M
Financing Cash Flow 567.4M 1.2B 367.0M 1.1B 724.4M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...